USFDA has started approving Indian drugs for US market as part of HCQ deal.

[Anik101]

#MarketswithMC | Cadila Healthcare share price touched 52-week high, rising 8% intraday after the company received final approval from #USFDA for a blood #cancer drug #stockmarket #stockstowatch

https://twitter.com/x/status/1248141075341955077

Cipla Gets U.S. FDA Nod For Generic Inhaler Amid Coronavirus Pandemic

Read more at: https://www.bloombergquint.com/mark...for-generic-inhaler-amid-coronavirus-pandemic
Granules India receives USFDA approval for Butalbital, Acetaminophen and Caffeine Capsules

https://www.business-standard.com/a...hen-and-caffeine-capsules-120040900523_1.html


Cadila Healthcare stock rises 12% on nod for Perphenazine tablets from USFDA
https://m.businesstoday.in/lite/sto...ises-perphenazine-tablets-usfda/1/400495.html
USFDA was once hell bent on destroying Indian pharmaceutical industry by denying them free access to US market. Someone in MEA needs to be awarded for negotiating HCQ deal.

 

[Thamizh Puli]

Indian pharmas better make sure the factories, labs and QC processes are absolutely perfect. Over the past 10 years while 98%+ (my approximate guess) have had fantastic records, there are some exceptions that have been a problem. AS the US approves more and more, it is important that quality becomes 100%.